A novel semiautomated method for background activity and biological tumour volume definition to improve standardisation of
18F-FET PET
Background activity
Glioma
Method standardisation
PET imaging
Journal
EJNMMI physics
ISSN: 2197-7364
Titre abrégé: EJNMMI Phys
Pays: Germany
ID NLM: 101658952
Informations de publication
Date de publication:
05 Feb 2022
05 Feb 2022
Historique:
received:
29
07
2021
accepted:
24
01
2022
entrez:
5
2
2022
pubmed:
6
2
2022
medline:
6
2
2022
Statut:
epublish
Résumé
Multicentre clinical trials evaluating the role of Compared to the gCS method, the MI method showed significantly lower intra- and inter-reader variability both in background activity and in BTV definition. The proposed semiautomated MI method minimises intra- and inter-reader variability, providing a valuable approach for standardisation of
Sections du résumé
BACKGROUND
BACKGROUND
Multicentre clinical trials evaluating the role of
RESULTS
RESULTS
Compared to the gCS method, the MI method showed significantly lower intra- and inter-reader variability both in background activity and in BTV definition.
CONCLUSIONS
CONCLUSIONS
The proposed semiautomated MI method minimises intra- and inter-reader variability, providing a valuable approach for standardisation of
Identifiants
pubmed: 35122529
doi: 10.1186/s40658-022-00438-2
pii: 10.1186/s40658-022-00438-2
pmc: PMC8818070
doi:
Types de publication
Journal Article
Langues
eng
Pagination
9Subventions
Organisme : national health and medical research council
ID : APP1132471
Organisme : national health and medical research council
ID : APP1194004
Organisme : cancer institute nsw
ID : 2019/ECF1015
Organisme : commonwealth scientific and industrial research organisation
ID : Probing Biosystems Future Science Platform
Informations de copyright
© 2022. The Author(s).
Références
J Nucl Med. 2011 Jun;52(6):856-64
pubmed: 21622893
Neurosurgery. 2005 Sep;57(3):505-11; discussion 505-11
pubmed: 16145529
Neuro Oncol. 2021 Jun 1;23(6):881-893
pubmed: 33538838
Eur Radiol. 2015 Oct;25(10):3017-24
pubmed: 25813014
Neuro Oncol. 2016 Sep;18(9):1199-208
pubmed: 27106405
PLoS One. 2020 Apr 17;15(4):e0230618
pubmed: 32302317
EJNMMI Res. 2017 Dec;7(1):48
pubmed: 28560582
EJNMMI Res. 2018 Jul 31;8(1):72
pubmed: 30066053
Eur J Nucl Med Mol Imaging. 2004 Nov;31(11):1464-70
pubmed: 15248032
Med Phys. 2017 Jun;44(6):e1-e42
pubmed: 28120467
Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):373-381
pubmed: 27554774
Radiother Oncol. 2016 Oct;121(1):132-137
pubmed: 27622554
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):603-613
pubmed: 30276440
Bioengineering (Basel). 2018 Nov 28;5(4):
pubmed: 30487391
Eur J Nucl Med Mol Imaging. 2006 Nov;33(11):1374-80
pubmed: 16932934
Neuro Oncol. 2015 Sep;17(9):1293-300
pubmed: 26008606
Brain. 2005 Mar;128(Pt 3):678-87
pubmed: 15689365
Eur Radiol. 2017 Jul;27(7):2916-2927
pubmed: 27853813
Eur J Nucl Med Mol Imaging. 2015 Apr;42(5):685-95
pubmed: 25411133
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
Neuro Oncol. 2015 May;17(5):757-63
pubmed: 25537018
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):540-557
pubmed: 30519867
Psychol Bull. 1979 Mar;86(2):420-8
pubmed: 18839484
Neuroimage Clin. 2017 Nov 08;17:491-497
pubmed: 29159062
Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):22-33
pubmed: 23053325
Radiat Oncol. 2016 Jun 24;11:87
pubmed: 27342976
Radiat Oncol. 2016 Oct 21;11(1):139
pubmed: 27769279
Neurooncol Adv. 2019 May 28;1(1):vdz010
pubmed: 32642650
Strahlenther Onkol. 2012 Apr;188(4):334-9
pubmed: 22349712
PLoS One. 2020 Mar 30;15(3):e0230901
pubmed: 32226030